Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female Ward/Bed No: W15B07

Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(ASPIRIN/ ACETYLSALICYLIC ACID/ ASA) (80 mg/PO/OD)

Indication: prevention of pre-eclampsia Classification: PHARMACOTHERAPEUTIC- Nonsteroidal salicylate

NURSING RESPONSIBILITIES:
Indications for Use: (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list
Analgesia all, and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Treatment of fever; anti-pyretic
Anti-inflammation
Preparation: Administration: Monitoring
Reduces inflammation related to rheumatoid
arthritis (RA), juvenile arthritis, osteoarthritis,
rheumatic fever Do not give to children or teenagers Administer after meals or with food Assess skin for evidence of
Used as platelet aggregation inhibitor in the who have or recently had viral or an antacid to minimize gastric ecchymosis.
prevention of transient ischemic attacks, (TIAs), infections (increases irritation. Food slows but does not Monitor urinary pH (sudden
cerebral thromboembolism, MI or reinfarction. risk of Reye’s syndrome) alter the total amount absorbed. acidification, pH from 6.5 to 5.5,
Adjunctive treatment of Kawasaki’s disease. Do not use if vinegar-like odor is may result in toxicity).
noted (indicates chemical If given as anti-pyretic, assess
breakdown) temperature directly before and 1 hr
Assess type, location, duration of after giving medication.
pain, inflammation. Report tinnitus or persistent
Inspect appearance of affected abdominal GI pain, bleeding.
Contraindications: joints for immobility, deformities, Evaluate for therapeutic response:
Hypersensitivity to salicylates, NSAIDS skin condition. relief of pain, stiffness, swelling;
Asthma, rhinitis, nasal polyps
Do not break, crush, dissolve, or increased joint mobility; reduced
Inherited or acquired bleeding disorders
Use in children (younger than divide enteric-coated tablets. joint tenderness; improved grip
16 yrs) for viral infections. Chewable tablets may be chewed, strength.
dissolved in liquid, or swallowed
whole.
Some extended-release tablets
may be broken or crumbled but
must not be ground up before
swallowing. See manufacturer’s
prescribing information for
individual products.

References:
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female
Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016
(CALCIUM CARBONATE) (1 tab/PO/BID)

Indication:treatment, prevention of calcium deficiency Classification: Therapeutic- mineral and electrolyte replacements/ supplements
NURSING RESPONSIBILITIES:
Indications for Use: (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list
Antacid all, and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Treatment/prevention of calcium deficiency
Treatment/prevention of hyperphosphatemia.
Preparation: Administration: Monitoring

Do not confuse Os-Cal (calcium Administer calcium carbonate or
carbonate) with Asacol phosphate 1–1.5 hr after meals and
(mesalamine). at bedtime.
Dissolve effervescent tablets in Follow oral doses with a full glass
glass of water. of water, except when using
calcium carbonate as a phosphate
. binder in renal dialysis.
Administer on an empty stomach
before meals to optimize
effectiveness in patients with
Contraindications: hyperphosphatemia.
Hypercalcemia; Remind client to thoroughly chew
Renal calculi
chewable tablets before
Ventricular fibrillation;
Concurrent use of calcium supplements (calcium acetate) swallowing.
Monitor serum BMP, calcium,
ionized calcium, magnesium,
phosphate
Monitor B/P, cardiac rhythm, renal
function.
Monitor for signs of hypercalcemia.
Advise patient that calcium
carbonate may cause constipation.
Review methods of preventing
constipation (increasing bulk in diet,
increasing fluid intake, increasing
mobility) and using laxatives.
Severe constipation may indicate
toxicity.

References:
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(FERROUS SULFATE) (1 tab/PO/OD)

Indication:prevention/treatment of iron-deficiency anemia Classification: Pharmacologic- iron supplements
NURSING RESPONSIBILITIES:
Indications for Use: (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list
Prevention, treatment of iron deficiency anemia due to all, and then tick the boxes applicable for your patient. Include IV and oral preparations.)
inadequate diet, malabsorption, pregnancy, blood loss.
Dietary supplement for iron
Preparation: Administration: Monitoring

Store all forms (tablets, capsules, Discontinue oral iron preparations
suspension,drops) at room prior to parenteral administration.
temperature. Oral preparations are most
Do not crush or chew enteric- effectively absorbed if administered
coated tablets and do not open 1 hr before or 2 hr after meals.
capsules. If gastric irritation occurs,
administer with meals.
Take tablets and capsules with a
full glass of water or juice.
Liquid preparations may stain teeth.
Contraindications: Dilute in water or fruit juice, full
Hemochromatosis, hemosiderosis, or other evidence of iron glass (240 mL) for adults and 1/2
overload;
glass (120 mL) for children, and
Anemias not due to iron deficiency;
Some products contain alcohol, tartrazine, or sulfites and administer with a straw or place
should be avoided in patients with known intolerance or drops at back of throat.
hypersensitivity.
Monitor serum iron, total iron-
binding capacity, reticulocyte count,
Hgb, ferritin.
Monitor daily pattern of bowel
activity stool consistency.
Assess for clinical
improvement,record relief of iron
deficiency symptoms (fatigue,
irritability, pallor, paresthesia of
extremities, headache).
Advise patient that stools may
become dark green or black and
that this change is harmless.

Indications for Use:

Contraindications:
Known
Dietaryalcohol intolerance
supplement for the treatment and prevention of
Hypersensitivity to preservatives, colorants, additives,
vitamin deficiencies.
including tartrazine, saccharin, aspartame (oral forms) References:
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female
Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(MULTIVITAMIN) (1 tab/PO/OD)

Indication: treatment, prevention of vitamin deficiencies Classification: multivitamin

References: NURSING RESPONSIBILITIES:
Patient’s Name: JOSIE BAROTILLO VELASCO (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list
Age/Sex: 28 y/o, all, and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Female Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech
in threatened pre-term labor Date of Assignment: September 27, Preparation: Administration: Monitoring
2016
For IV preparations: Dilute the For PO: Do not take more than the For IV: Clinical status and vitamin
(MICRONIZED PROGESTERONE) levels should be monitored in patients
(200 mg/tab/ODHS per vagina)
contents of Vial 1 (5mL) and the recommended dosage. If you are
contents of Vial 2 (5mL) in not less uncertain about any of the receiving parenteral multivitamins as
(PROMETRIUM) the only source of vitamins for
Indication: Secondary amenorrhea and abnormal uterine bleeding due to than 500 mL infusion fluid, both information, consult your doctor or
extended periods of time. It is
hormonal imbalance Classification: Therapeutic- hormones vials to be used for a single dose. pharmacist.
particulary important to monitor for
The VialRESPONSIBILITIES:
NURSING 1 and Vial 2 container adequate supplementation of, for
Indications for Use: (Thisclosures
should may
includebe all
penetrated
warnings,only
specific instructions on preparation, mixing, administration, monitoring, etc. You may list
example:
Secondary amenorrhea and abnormal uterine bleeding one then
all, and time,tick
utilizing a suitable
the boxes sterile for your patient. Include IV and oral preparations.)
applicable • Vitamin A in patients with pressure ulcers,
due to hormonal imbalance. transfer device or dispensing set, wounds, burns, short bowel syndrome or
Prevention of cell overgrowth in the uterine lining in which allows measured distribution cystic fibrosis
Preparation: Administration: Monitoring
postmenopausal women who have not had a of the contents. • Vitamin B1 in dialysis patients
hysterectomy (with estrogen). • Vitamin B2 in cancer patients
Part of assisted reproductive technology (ART) in the Vaginal Gel: Remove
The withdrawal applicator
of container PO: If given in morning, administer • Vitamin
BP beB6monitored
in patientsperiodically
with renal during
management of infertility (4% and 8% vaginal gel) from sealed
contents wrapper.
should Do not
be accomplished 2 hrs after breakfast with full glass impairment
therapy.and Individual vitamins whose
. remove twist-off tabsolution
at this time. of water. requirements
Monitor intake and output due
may be increased to and
ratios
without delay. The should
interactions with other medicines (See
Hold applicator by thick end.
be administered within 4 hours Shake
after Vaginal: Hold applicator by flat weekly weight. Report significant
Interactions with other medicines)
down several
dilution. times (like a section of thick end and twist off tab discrepancies or steady weight
thermometer) to ensure contents at other end. Do not squeeze thick gain.
are at thin end. end while twisting tab (could force Advise patient to report signs and
some gel to be released before symptoms of fluid retention
insertion). (swelling of ankles and feet, weight
Insert applicator into vagina either gain), thromboembolic disorders
Contraindications: in sitting position or lying on back (pain, swelling, tenderness in
Hypersensitivity; with knees bent. extremities, headache, chest pain,
Hypersensitivity o parabens or sesame oil (IM
Insert thin end well into vagina. blurred vision), mental depression,
suspension only);
Hypersensitivity to peanuts (Prometrium only); Squeeze thick end of applicator to or hepatic dysfunction (yellowed
Thromboembolic disease; deposit gel skin or eyes, pruritus, dark urine,
Cerebrovascular disease; Remove applicator, discard. lightcolored stools) to health care
Severe liver disease; professional.
Breast or genital cancer; Porphyria; .
Missed abortion;
OB: Contraindicated except in
corpus luteum dysfunction.
References: